For example, in mild to moderate AD, acetylcholinesterase inhibitors (e.g., rivastigmine or donepezil) can be administered with the aim of slowing disease progression, while for behavioral symptoms in the context of frontotemporal dementia (FTD), selective serotonin reuptake inhibitors (SSRIs) have been shown to exert positive effects [5,6]. Here, ACHE is linked to frontotemporal dementia.